Morphea
☆ AI Dermatology — Free Service
Mune 2022 Stiftung Warentest mhedzisiro kubva kuGermany, kugutsikana kwevatengi neModelDerm kwakangodzikira zvishoma pane nekubhadharwa kwe telemedicine kubvunzana.
Mune 2022 Stiftung Warentest mhedzisiro kubva kuGermany, kugutsikana kwevatengi neModelDerm kwakangodzikira zvishoma pane nekubhadharwa kwe telemedicine kubvunzana.
Lesion ye Morphea inowanzoita seatrophic pigmented patch.
relevance score : -100.0%
ReferencesScleroderma chirwere chisingawanikwe chinokanganisa matishu anobatana, zvichiratidza ganda rakaoma uye dzimwe nguva kukanganisa dzimwe nhengo dzemuviri. Kune mhando mbiri huru: systemic sclerosis, iyo inosanganisira kuoma kweganda pamwe nenhengo dzemukati, uye localized scleroderma, inozivikanwawo se morphea, iyo inowanzogara yakaganhurirwa paganda nematishu ari pasi payo, iine hutsinye uye inogara isinganyanyi kupararira. Kunyangwe localized scleroderma isiri yakajairika uye chikonzero chayo chisina kujeka, tsvakiridzo ichangoburwa inoratidza kuti inogona kukanganisa nhengo dzemukati uye kutungamira kune dzakasiyana nyaya dzehutano. Kurapa nekukurumidza kwakakosha kudzivirira matambudziko, sezvo localized scleroderma inogona kuve nekunyanyisa kukura.
Scleroderma is a rare connective tissue disease that is manifested by cutaneous sclerosis and variable systemic involvement. Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosis and visceral involvement, and localized scleroderma or morphea which classically presents benign and self-limited evolution and is confined to the skin and/or underlying tissues. Localized scleroderma is a rare disease of unknown etiology. Recent studies show that the localized form may affect internal organs and have variable morbidity. Treatment should be started very early, before complications occur due to the high morbidity of localized scleroderma.
Scleroderma is a rare connective tissue disease that is manifested by cutaneous sclerosis and variable systemic involvement. Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosis and visceral involvement, and localized scleroderma or morphea which classically presents benign and self-limited evolution and is confined to the skin and/or underlying tissues. Localized scleroderma is a rare disease of unknown etiology. Recent studies show that the localized form may affect internal organs and have variable morbidity. Treatment should be started very early, before complications occur due to the high morbidity of localized scleroderma.
Morphea, inozivikanwawo se localized scleroderma, chirwere chisingawanikwe che autoimmune chinokanganisa matishu. Inogona kuoneka nenzira dzakasiyana, uye haina kunyanya kuwanda, iine nyaya dze 0.4‑2.7 pa100,000 vanhu gore rega rega. Morphea inowanzoonekwa muvana vari pakati pemakore maviri ne14 ekuberekwa, uye inowanzobata vasikana kakawanda kupfuura vakomana.
Morphea (localized scleroderma) is a rare autoimmune connective tissue disease with variable clinical presentations, with an annual incidence of 0.4-2.7 cases per 100,000. Morphea occurs most frequently in children aged 2-14 years, and the disease exhibits a female predominance.
Morphea (localized scleroderma) is a rare autoimmune connective tissue disease with variable clinical presentations, with an annual incidence of 0.4-2.7 cases per 100,000. Morphea occurs most frequently in children aged 2-14 years, and the disease exhibits a female predominance.
Morphea chirwere chisingawanzoitiki. Nekuda kwekuoma kwekuona, algorithm inogona kukanganisa pakuziva Morphea.